Bio-IT World September 3, 2024
Jerry Murry, senior vice president, process and development, at Amgen, gave the plenary presentation at CHI’s Bioprocessing Summit last month. With an eighteen-year tenure at Amgen—and experience at Merck and Pfizer before that—Murry has seen nearly two decades of advances in the world of bioprocessing and manufacturing.
He spent a good deal of time talking about the advances in bioprocessing and bioreactor design, but he also touched on Amgen’s AI achievements and next steps.
An early use case has been using automated visual inspection—computer vision—to confirm quality for syringes and vials. All product receives visual inspection. Initially this was done manually, but the percentage of visual inspection that has been done automatically using...
Today's Sponsors
Today's Sponsor